NPPB and systemic sclerosis: When adjusted by age, male sex, SSc disease duration, and FVC, patients in the intermediate risk NT-proBNP group had a HR of 9.35 (95% CI: 3.12, 28.05) for all-cause mortality compared to those in the low risk NT-proBNP group.